- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 8, 2026 | 10.89M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 10.01M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 9.33M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $125K |
| Capex restated | Q1 2026 · Mar 31, 2025 | $168K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$16.52M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$12.49M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $600K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $12.24M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $26.19M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $43.04M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | −$53.37M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | −$40.82M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $38.3M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $38.85M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $76.54M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $74.85M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $47.03M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $59.82M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $102.74M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $117.89M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.99 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$1.36 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.99 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$1.36 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $9.55M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $4.34M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $4.07M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $3.66M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$19.88M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$12.66M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$21.1M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$9.08M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | −$7.48M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | −$1.08M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $11.81M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $2.22M |
| Revenue | Q1 2026 · Mar 31, 2026 | $4.33M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $1.15M |